Description
2022 PUBLIC LAW PRICING UPDATES
Base award description: BPA FOR OCALIVA
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-01-20+$0= $0
- Mod P000012017-10-27+$0= $0
- Mod P000022017-12-27+$0= $0
- Mod P000032018-01-04+$0= $0
- Mod P000042018-12-27+$0= $0
- Mod P000052019-01-17+$0= $0
- Mod P000062019-12-11+$0= $0
- Mod P000072019-12-31+$0= $0
- Mod P000082020-11-20+$0= $0
- Mod P000092020-12-07+$0= $0
- Mod P000102021-12-27+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-01-20 | +$0 | $0 | BPA FOR OCALIVA |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2017-10-27 | +$0 | $0 | REVISED OCALIVA ORDERING FORMS AND UPDATED ADDRESS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-12-27 | +$0 | $0 | 2018 PUBLIC LAW UPDATES |
| Mod P00003· EXERCISE AN OPTION | 2018-01-04 | +$0 | $0 | EXERCISE OPTION YEAR |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-12-27 | +$0 | $0 | 2019 PUBLIC LAW UPDATES |
| Mod P00005· EXERCISE AN OPTION | 2019-01-17 | +$0 | $0 | EXERCISE SECOND OPTION YEAR |
| Mod P00006· EXERCISE AN OPTION | 2019-12-11 | +$0 | $0 | EXERCISE THIRD OPTION YEAR |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-12-31 | +$0 | $0 | 2020 PUBLIC LAW PRICING UPDATES |
| Mod P00008· EXERCISE AN OPTION | 2020-11-20 | +$0 | $0 | EXERCISE THE 4TH AND FINAL OPTION YEAR WITH NO PRICE CHANGES |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-12-07 | +$0 | $0 | 2021 PUBLIC LAW PRICING UPDATES |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-27 | +$0 | $0 | 2022 PUBLIC LAW PRICING UPDATES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GHNKCLBJRMK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79725A0001 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36F79724D0180 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36E79722A0011 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36C24920F0531 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $49,147 | FY2020 |
| 36C24719K0039 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS | $4,363 | FY2019 |
| 36C26119F0005 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $26,401 | FY2019 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P17A0002_3600 · retrieved 2026-09-26.